“We’re now in a very exciting time where we have treatments with previously unseen capacity to improve the control of type 2 diabetes and help our patients manage weight,” said Dr. Sue Pedersen, a specialist in endocrinology and metabolism from Calgary, during a webinar hosted by Benefits Canada and sponsored by Eli Lilly Canada in […]
In 2022, some of the top chronic conditions affecting group benefits plans were diabetes, obesity, depression and arthritis. Diabetes was the No. 1 ranked condition for drug claims in 2022, knocking rheumatoid arthritis down to the No. 2 spot, according to Telus Health’s annual drug plan trends report. And the 2023 Benefits Canada Healthcare Survey […]
Half (51 per cent) of plan members say the coverage levels of at least one of their health benefits limit their ability to seek necessary treatment, jumping to 84 per cent among those with a major injury in the past 12 months, according to the 2023 Benefits Canada Healthcare Survey. It found this percentage increased […]
Half (51 per cent) of Canadian benefits plan members say they understand their plan extremely or very well, down from 65 per cent in 2018, according to the 2023 Benefits Canada Healthcare Survey. It found plan members’ top sources for information about their benefits plan were websites (69 per cent), followed at some distance by […]
More than half (54 per cent) of Canadian benefits plan members currently live with at least one diagnosed chronic health condition, according to the 2023 Benefits Canada Healthcare Survey. It found the top current diagnoses were a mental-health condition such as depression or anxiety (18 per cent), high cholesterol (12 per cent), arthritis (12 per […]
An article on how global pension funds compare in terms of transparency was the most-read story on BenefitsCanada.com over the last week. Here are the five most popular news stories of the week: 1. Five Canadian pension funds receive top scores for transparency: benchmark 2. How plan sponsors, insurers are considering coverage of weight-loss drugs amid rising use […]
Canadian plan sponsors and insurers are revisiting how they classify obesity drugs under their benefits plans, amid plan members’ rising demand for Ozempic as a weight-loss treatment. Ozempic, also known under the generic name semaglutide, is a drug used to treat type 2 diabetes. However, the medication has also been credited as a weight-loss treatment, […]
U.S. employers are increasing their family and caregiving benefits in 2023, according to a new survey by the Society for Human Resource Management. The survey, which polled more than 4,000 employers, found a quarter (25 per cent) said they cover infertility treatments and in vitro fertilization, while five per cent cover egg freezing for non-medical […]
The annual spend per private drug plan member increased by 6.3 per cent in 2022, according to Express Scripts Canada’s annual drug trends report. Across both traditional and specialty drugs, the increase was primarily driven by a 5.4 per cent rise in plan members making a claim, which reversed the trend seen in 2020 and […]
As the coronavirus pandemic enters its fourth year, it’s perhaps unsurprising that the health crisis has taken its toll on employee mental health. Scotiabank saw a notable rise in claims for mental-health drugs in 2022, says Ayman Alvi, the bank’s vice-president of global pension and benefits, noting the increased use of these medications aligns with […]